Andrew R. Pettitt
University of Liverpool(GB)Curtin University(AU)Clatterbridge Cancer Centre NHS Foundation Trust(GB)Oxford University Hospitals NHS Trust(GB)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, Cancer-related Molecular Pathways, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia(2014)1,675 cited
- → A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia(2008)360 cited
- → Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial(2015)338 cited
- → Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study(2019)266 cited
- → DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma(2019)260 cited
- → Relationship between p53 dysfunction, CD38 expression, andIgVH mutation in chronic lymphocytic leukemia(2002)246 cited